We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
The nexus of environmental endocrine-disrupting chemical exposure and metabolic dysfunction-associated steatotic liver disease: An emerging public health challenge
Summary
This review examines evidence that chronic low-dose exposure to endocrine-disrupting chemicals, including micro- and nanoplastics, may be an underappreciated factor driving the global rise of metabolic liver disease. Researchers found that these pollutants can promote liver fat accumulation, inflammation, and scarring by disrupting hormone signaling, gut health, and mitochondrial function. The study suggests that environmental chemical exposures should be considered alongside diet and lifestyle when assessing liver disease risk.
The global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has reached epidemic proportions, creating a substantial healthcare burden. While traditionally attributed to caloric excess and sedentary lifestyles, the incomplete explanation provided by these factors alone has spurred the investigation of novel etiological agents. There is now compelling evidence that chronic, low-dose exposure to environmental endocrine-disrupting chemicals (EDCs) is a significant and underappreciated risk factor driving MASLD pathogenesis. This review synthesizes the current human epidemiological and mechanistic evidence, focusing on the last five years, to elucidate the role of both established EDCs (e.g., phthalates, bisphenols, PFAS, organochlorine pesticides) and emerging contaminants, notably micro- and nanoplastics (MNPs). We detail how these pervasive pollutants promote hepatic steatosis, inflammation, and fibrosis by disrupting nuclear receptor signaling (e.g., PPARγ), inducing gut dysbiosis and barrier dysfunction, causing mitochondrial and lysosomal impairment, and reprogramming lipid metabolism. The review highlights that MNPs, in particular, represent a frontier in environmental hepatotoxicity, with recent data revealing their ability to bioaccumulate and exacerbate metabolic insults through novel mechanisms. By integrating evidence from population studies and experimental models, this review underscores the necessity of incorporating the "exposome" into the MASLD etiological framework. It concludes that mitigating this public health challenge requires concerted efforts in advancing research on chemical mixtures and critical exposure windows, alongside implementing policies aimed at reducing environmental exposure.
Sign in to start a discussion.
More Papers Like This
Adipose tissue as target of environmental toxicants: focus on mitochondrial dysfunction and oxidative inflammation in metabolic dysfunction-associated steatotic liver disease
This review examines how environmental toxicants, including micro and nanoplastics, target fat tissue and contribute to metabolic diseases like obesity, diabetes, and fatty liver disease. These pollutants disrupt mitochondria (the energy-producing parts of cells) and trigger a cycle of oxidative stress and inflammation that damages both fat tissue and the liver. The findings suggest that microplastic exposure could be one of several environmental factors contributing to the rising rates of metabolic disease worldwide.
Microplastics and nanoplastics: Emerging drivers of hepatic pathogenesis and metabolic dysfunction
This review examines emerging evidence linking micro- and nanoplastic exposure to liver disease, including metabolic dysfunction-associated liver disease, cirrhosis, and liver cancer. Researchers found that these particles may contribute to liver damage through oxidative stress, inflammation, and disruption of metabolic pathways. The study highlights the need for further research into how environmental plastic contamination may be influencing the rising rates of liver disease worldwide.
Overview of the hazardous impacts of metabolism-disrupting chemicals on the progression of fatty liver diseases.
This review examined how metabolism-disrupting chemicals (MDCs)—including bisphenol A and phthalates from plastics—promote the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD). MDC exposure was found to impair liver lipid homeostasis and contribute to the global rise in fatty liver disease.
Chronic Nanoplastic Exposure Promotes the Development and Progression of Metabolic Dysfunction‐Associated Steatotic Liver Disease
This study found that chronic exposure to nanoplastics promotes the development and worsening of metabolic dysfunction-associated steatotic liver disease (formerly known as fatty liver disease). Nanoplastics appear to increase vulnerability to liver disease progression. The finding is concerning because fatty liver disease is already widespread, and everyday nanoplastic exposure through food and water could be making it worse.
Microplastics in metabolic dysfunction-associated steatotic liver disease: An emerging threat to liver health
This review examined emerging evidence linking microplastic exposure to the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD). The authors found that microplastics detected in liver tissue can exacerbate hepatic inflammation, lipid accumulation, and oxidative stress through multiple mechanisms, adding a novel environmental risk factor to MASLD pathogenesis.